Sharper aim for liver cancer: MRI guides radiation to spare healthy tissue
NCT ID NCT05027711
Summary
This study is testing if a new, more precise type of radiation therapy can better control cancer that has spread to the liver while causing fewer side effects. It will compare MRI-guided radiation, which uses real-time imaging to target tumors more accurately, against the current standard radiation method. The trial will enroll about 90 adults with 1-3 small liver tumors from other cancers to see which approach is safer and more effective.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATIC METASTASIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Hospital of Heidelberg, Radiation Oncology
RECRUITINGHeidelberg, 69120, Germany
Contact
Conditions
Explore the condition pages connected to this study.